AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.7480
-0.0320 (-4.10%)
At close: Sep 17, 2025, 4:00 PM EDT
0.7510
+0.0030 (0.40%)
After-hours: Sep 17, 2025, 4:10 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $8.71 million as of September 17, 2025. Its market cap has decreased by -76.80% in one year.
Market Cap
8.71M
Enterprise Value
16.85M
1-Year Change
-76.80%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $8.71M, a decrease of -86.32%. That is a compound annual growth rate of -36.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 9.08M | -57.92% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |